KIDRON NADAV
Reporting owner on Forms 3, 4 and 5, CIK 1351779.
KIDRON NADAV reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-25.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. CIK 1176309 | director, officer (President and CEO) | 1 | 2026-09-25 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. Common Stock | 2026-09-24 | A granted | +349,497 | 3,771,740 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Common Stock | 2026-09-24 | A granted | +368,765 | 4,140,505 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Common Stock, holding | 126,000 | Form 4 | ||||
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -196,500 | 0 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -190,000 | 0 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -49,000 | 0 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -97,000 | 0 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -150,000 | 0 | Form 4 | |
| ORAMED PHARMACEUTICALS INC. Stock option (right to buy), derivative | 2026-09-24 | D returned to the issuer | -107,000 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001213900-26-103540 | ORAMED PHARMACEUTICALS INC. | 2026-09-25 |